Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension, February 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 90 articles:
HTML format


 

Single Articles

  1. MAHGOUB L, Kaddoura T, Kameny AR, Lopez Ortego P, et al
    Pulmonary vein stenosis of ex-premature infants with pulmonary hypertension and bronchopulmonary dysplasia, epidemiology, and survival from a multicenter cohort.
    Pediatr Pulmonol. 2017 Feb 2. doi: 10.1002/ppul.23679.
    Abstract    

    Abstract available

  2. MORANDI F
    [European guidelines on the management of pulmonary hypertension: what's new?]
    G Ital Cardiol (Rome). 2016;17:954-958.
    Abstract    



  3. BOCHENEK ML, Rosinus NS, Lankeit M, Hobohm L, et al
    From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension.
    Thromb Haemost. 2017 Feb 2. doi: 10.1160/TH16-10-0790.
    Abstract    

    Abstract available

  4. KIM MJ, Jung HO
    Pulmonary hypertension: a long-term risk stratifier in primary mitral regurgitation.
    Ann Transl Med. 2016;4:541.
    Abstract    



  5. XU YP, He Q, Shen Z, Shu XL, et al
    MiR-126a-5p is involved in the hypoxia-induced endothelial-to-mesenchymal transition of neonatal pulmonary hypertension.
    Hypertens Res. 2017 Feb 2. doi: 10.1038/hr.2017.
    Abstract    

    Abstract available

  6. ARKHIPOVA OA, Martynyuk TV, Chazova IE
    [A clinical case of long-term macitentan therapy in a female patient with idiopathic pulmonary hypertension].
    Ter Arkh. 2016;88:88-93.
    Abstract    

    Abstract available

  7. CHEN PI, Cao A, Miyagawa K, Tojais NF, et al
    Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension.
    JCI Insight. 2017;2:e90427.
    Abstract    

    Abstract available

  8. GUAZZI M
    Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation.
    Eur J Heart Fail. 2017 Jan 30. doi: 10.1002.
    Abstract    



  9. HORINOUCHI T, Mazaki Y, Terada K, Higashi T, et al
    Current progress in therapeutic agents for pulmonary arterial hypertension: new insights into their mechanisms of action from endothelin system.
    Nihon Yakurigaku Zasshi. 2016;148:231-238.
    Abstract    



  10. CHEN H, Yang H, Xu C, Yue H, et al
    Gene expression profiling of common signal transduction pathways affected by rBMSCs/F92A-Cav1 in the lungs of rat with pulmonary arterial hypertension.
    Biomed Pharmacother. 2016;83:100-106.
    Abstract    

    Abstract available

  11. AYME-DIETRICH E, Banas SM, Monassier L, Maroteaux L, et al
    [Pulmonary arterial hypertension, bone marrow, endothelial cell precursors and serotonin].
    Biol Aujourdhui. 2016;210:79-88.
    Abstract    

    Abstract available

  12. TU L, Ghigna MR, Phan C, Bordenave J, et al
    [Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications].
    Biol Aujourdhui. 2016;210:65-78.
    Abstract    

    Abstract available

  13. SANTOS-RIBEIRO D, Mendes-Ferreira P, Maia-Rocha C, Adao R, et al
    Pulmonary arterial hypertension: Basic knowledge for clinicians.
    Arch Cardiovasc Dis. 2016;109:550-561.
    Abstract    

    Abstract available

  14. PEROSA F, Favoino E, Favia IE, Vettori S, et al
    Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease.
    Medicine (Baltimore). 2016;95:e3931.
    Abstract    

    Abstract available

  15. FUSSNER LA, Krowka MJ
    Current Approach to the Diagnosis and Management of Portopulmonary Hypertension.
    Curr Gastroenterol Rep. 2016;18:29.
    Abstract    

    Abstract available

  16. LI G, Tang L, Jia P, Zhao J, et al
    Elevated Plasma Connective Tissue Growth Factor Levels in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
    Pediatr Cardiol. 2016;37:714-21.
    Abstract    

    Abstract available

  17. MENG ML, Landau R, Viktorsdottir O, Banayan J, et al
    Pulmonary Hypertension in Pregnancy: A Report of 49 Cases at Four Tertiary North American Sites.
    Obstet Gynecol. 2017 Feb 6. doi: 10.1097/AOG.0000000000001896.
    Abstract    

    Abstract available

  18. DING X, Zhou S, Li M, Cao C, et al
    Upregulation of SRF Is Associated with Hypoxic Pulmonary Hypertension by Promoting Viability of Smooth Muscle Cells via Increasing Expression of Bcl-2.
    J Cell Biochem. 2017 Feb 8. doi: 10.1002/jcb.25922.
    Abstract    

    Abstract available

  19. KARAKUS G, Zencirci E, Degirmencioglu A, Guvenc TS, et al
    Easily measurable, noninvasive, and novel finding for pulmonary hypertension: Hypertrophy of the basal segment of septomarginal trabeculation of right ventricle.
    Echocardiography. 2017 Feb 6. doi: 10.1111/echo.13461.
    Abstract    

    Abstract available

  20. BOUVAIST H
    [Balloon pulmonary angioplasty: An additional treatment option to improve the status of patients with chronic thromboembolic pulmonary hypertension].
    Rev Pneumol Clin. 2017 Feb 2. pii: S0761-8417(16)30097.
    Abstract    

    Abstract available

  21. MESTAN KK, Gotteiner N, Porta N, Grobman W, et al
    Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
    J Pediatr. 2017 Feb 2. pii: S0022-3476(17)30033.
    Abstract    

    Abstract available

  22. CHIU JS, Ma L, Wynn J, Krishnan U, et al
    Mutations in BMPR2 are not present in patients with pulmonary hypertension associated with congenital diaphragmatic hernia.
    J Pediatr Surg. 2017 Jan 26. pii: S0022-3468(17)30039.
    Abstract    

    Abstract available

  23. MAINARDI AS, Trow T
    Tumor Emboli: A Rare Cause of Acute Pulmonary Hypertension.
    Am J Med. 2017 Jan 31. pii: S0002-9343(16)31237.
    Abstract    



  24. HANNA LA, Basalious EB, ELGazayerly ON
    Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption.
    Drug Deliv. 2016;24:188-198.
    Abstract    

    Abstract available

  25. LEE SH, Kwon BS, Kim GB, Bae EJ, et al
    Prophylactic Pulmonary Artery Reduction in a Young Female with Severe Pulmonary Hypertension from Complete Atrioventricular Septal Defect.
    Korean Circ J. 2017;47:136-140.
    Abstract    

    Abstract available

  26. DAROCHA S, Pietura R, Pietrasik A, Norwa J, et al
    Improvement in Quality of Life and Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension Treated With Balloon Pulmonary Angioplasty.
    Circ J. 2017 Feb 1. doi: 10.1253/circj.CJ-16-1075.
    Abstract    

    Abstract available

  27. CASTRO MG
    Biomarkers in pulmonary hypertension: An ongoing quest for better outcomes.
    Rev Port Cardiol. 2017 Jan 30. pii: S0870-2551(16)30430.
    Abstract    



  28. KNAI K, Skjaervold NK
    A pig model of acute right ventricular afterload increase by hypoxic pulmonary vasoconstriction.
    BMC Res Notes. 2017;10:2.
    Abstract    

    Abstract available

  29. HOA S, Hudson M, Troyanov Y, Proudman S, et al
    Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.
    Medicine (Baltimore). 2016;95:e4713.
    Abstract    

    Abstract available

  30. PENG H, Xiao Y, Deng X, Luo J, et al
    The Warburg effect: A new story in pulmonary arterial hypertension.
    Clin Chim Acta. 2016;461:53-8.
    Abstract    

    Abstract available

  31. OOTAKI Y, Verghese GR, Ungerleider RM
    Development of chylous ascites in an infant with ventricular septal defect: a case report.
    Cardiol Young. 2016;26:1225-7.
    Abstract    

    Abstract available

  32. THANKAVEL PP, Ramaciotti C
    Early echocardiographic predictor of heart failure in cerebral arteriovenous malformations.
    Cardiol Young. 2016;26:1008-12.
    Abstract    

    Abstract available

  33. NAIR AK, Radhakrishnan S, Iyer KS
    Descending aortic flow reversal in obstructed total anomalous pulmonary venous connection.
    Cardiol Young. 2016;26:1002-4.
    Abstract    

    Abstract available

  34. BAGGEN VJ, Leiner T, Post MC, van Dijk AP, et al
    Cardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysis.
    Eur Radiol. 2016;26:3771-3780.
    Abstract    

    Abstract available

  35. ADDETIA K, Maffessanti F, Yamat M, Weinert L, et al
    Three-dimensional echocardiography-based analysis of right ventricular shape in pulmonary arterial hypertension.
    Eur Heart J Cardiovasc Imaging. 2016;17:564-75.
    Abstract    

    Abstract available

  36. AITHALA R, Alex AG, Danda D
    Pulmonary hypertension in connective tissue diseases: an update.
    Int J Rheum Dis. 2017 Feb 16. doi: 10.1111/1756-185X.13001.
    Abstract    

    Abstract available

  37. WANG MM, Li H, Zhang FF, Ma KT, et al
    [Role of calcium-sensing receptor in neonatal mice with persistent pulmonary hypertension].
    Zhongguo Dang Dai Er Ke Za Zhi. 2017;19:208-214.
    Abstract    

    Abstract available

  38. BERENZ A, Vergales JE, Swanson JR, Sinkin RA, et al
    Evidence of Early Pulmonary Hypertension Is Associated with Increased Mortality in Very Low Birth Weight Infants.
    Am J Perinatol. 2017 Feb 15. doi: 10.1055/s-0037-1598246.
    Abstract    

    Abstract available

  39. MAGNE J, Mohty D, Piccardo A, Boulogne C, et al
    Impact of Pulmonary Hypertension on Outcome in Patients with Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction.
    Clin Res Cardiol. 2017 Feb 14. doi: 10.1007/s00392-017-1085.
    Abstract    

    Abstract available

  40. KAWAKAMI T, Ogawa A, Miyaji K, Mizoguchi H, et al
    Response by Kawakami et al to Letter Regarding Article, "Novel Angiographic Classification of Each Vascular Lesion in Chronic Thromboembolic Pulmonary Hypertension Based on Selective Angiogram and Results of Balloon Pulmonary Angioplasty".
    Circ Cardiovasc Interv. 2017;10.
    Abstract    



  41. ROIK M, Wretowski D, Pruszczyk P
    Letter by Roik et al Regarding Article, "Novel Angiographic Classification of Each Vascular Lesion in Chronic Thromboembolic Pulmonary Hypertension Based on Selective Angiogram and Results of Balloon Pulmonary Angioplasty".
    Circ Cardiovasc Interv. 2017;10.
    Abstract    



  42. QUAIL MA, Muthurangu V
    An Unwelcome Embrace: Adverse Pulmonary-Aortic Interactions in Pulmonary Hypertension.
    Circ Cardiovasc Imaging. 2017;10.
    Abstract    



  43. SIANOS G, Giannakoulas G, Konstantinidis NV, Mouratoglou SA, et al
    A case of balloon pulmonary angioplasty as a palliative therapy in chronic thromboembolic pulmonary hypertension.
    Hellenic J Cardiol. 2016 Nov 16. pii: S1109-9666(16)30287.
    Abstract    



  44. WATANABE T, Abe K, Horimoto K, Hosokawa K, et al
    Subcutaneous treprostinil was effective and tolerable in a patient with severe pulmonary hypertension associated with chronic kidney disease on hemodialysis.
    Heart Lung. 2017 Feb 9. pii: S0147-9563(16)30394.
    Abstract    

    Abstract available

  45. NAGIUB M, Kanaan U, Simon D, Guglani L, et al
    Risk Factors for Development of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis.
    Paediatr Respir Rev. 2016 Nov 22. pii: S1526-0542(16)30126.
    Abstract    

    Abstract available

  46. CHENG G, Wang X, Li Y, He L, et al
    Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Stem Cell Res Ther. 2017;8:34.
    Abstract    

    Abstract available

  47. PTASZYNSKA-KOPCZYNSKA K, Krentowska A, Sawicka E, Skoneczny A, et al
    The strengths and weaknesses of non-invasive parameters obtained by echocardiography and cardiopulmonary exercise testing in comparison with the hemodynamic assessment by the right heart catheterization in patients with pulmonary hypertension.
    Adv Med Sci. 2016;62:39-44.
    Abstract    

    Abstract available

  48. INGRAM DG, Singh AV, Ehsan Z, Birnbaum BF, et al
    Obstructive Sleep Apnea and Pulmonary Hypertension in Children.
    Paediatr Respir Rev. 2017 Jan 11. pii: S1526-0542(17)30002.
    Abstract    

    Abstract available

  49. NETO-NEVES EM, Brown MB, Zaretskaia MV, Rezania S, et al
    Chronic Embolic Pulmonary Hypertension Caused by Pulmonary Embolism and Vascular Endothelial Growth Factor Inhibition.
    Am J Pathol. 2017 Feb 6. pii: S0002-9440(17)30027.
    Abstract    

    Abstract available

  50. VENTURA HO
    Foreword.
    Curr Probl Cardiol. 2017;42:5.
    Abstract    



  51. PARRY A, Higginson R, Gleeson A
    End-of-life prognostic indicators in patients with COPD: part 2.
    Int J Palliat Nurs. 2016;22:560-567.
    Abstract    

    Abstract available

  52. MONTANI D, Chaumais MC, Seferian A, Humbert M, et al
    [Mitomycin-induced pulmonary veno-occlusive disease: A rare but severe complication].
    Bull Cancer. 2017;104:202-204.
    Abstract    



  53. SARDANA M, Moll M, Farber HW
    Pharmacokinetic drug evaluation of selexipag for the treatment of pulmonary arterial hypertension.
    Expert Opin Drug Metab Toxicol. 2016;12:1513-1520.
    Abstract    

    Abstract available

  54. CAVAGNA L, Codullo V, Ghio S, Scire CA, et al
    Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients.
    Medicine (Baltimore). 2016;95:e4827.
    Abstract    

    Abstract available

  55. CHEN Q, Huang C, Zhang YJ
    The effect of intravertebral anesthesia on bone cement implantation syndrome in aged patients: A single-center 5-year retrospective study.
    Medicine (Baltimore). 2016;95:e4775.
    Abstract    

    Abstract available

  56. MORISHITA S, Hagihara M, Itabashi M, Ishii Y, et al
    Development of pulmonary arterial hypertension during oral dasatinib therapy for chronic myelogenous leukemia.
    Rinsho Ketsueki. 2016;57:999-1003.
    Abstract    

    Abstract available

  57. CHAISSON NF, Dodson MW, Elliott CG
    Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease.
    Clin Chest Med. 2016;37:523-34.
    Abstract    

    Abstract available

  58. EL-CHEMALY S, Young LR
    Hermansky-Pudlak Syndrome.
    Clin Chest Med. 2016;37:505-11.
    Abstract    

    Abstract available

  59. PARTRIDGE EA, Peranteau WH, Herkert L, Rendon N, et al
    Right- versus left-sided congenital diaphragmatic hernia: a comparative outcomes analysis.
    J Pediatr Surg. 2016;51:900-2.
    Abstract    

    Abstract available

  60. D'ANDREA A, D'Alto M, Di Maio M, Vettori S, et al
    Right atrial morphology and function in patients with systemic sclerosis compared to healthy controls: a two-dimensional strain study.
    Clin Rheumatol. 2016;35:1733-42.
    Abstract    

    Abstract available

  61. AMEDRO P, Basquin A, Gressin V, Clerson P, et al
    Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE study.
    Cardiol Young. 2016;26:1250-9.
    Abstract    

    Abstract available

  62. LEE S, Lytrivi ID, Roytman Z, Ko HH, et al
    Cardiomyopathy in children: Can we rely on echocardiographic tricuspid regurgitation gradient estimates of right ventricular and pulmonary arterial pressure?
    Cardiol Young. 2016.
    Abstract    

    Abstract available

  63. PAWAR R, Kumar G, Sharma V, Dalal SS, et al
    Unusual Case of Left Bronchial Compression by Aneurysmal Pulmonary Arteries in a Child With Atrial Septal Defect.
    World J Pediatr Congenit Heart Surg. 2016;7:509-12.
    Abstract    

    Abstract available

  64. HALLBERGSON A, Esch JJ, Tran TX, Lock JE, et al
    Systemic rapamycin to prevent in-stent stenosis in peripheral pulmonary arterial disease: early clinical experience.
    Cardiol Young. 2016;26:1319-26.
    Abstract    

    Abstract available

  65. KIDO T, Hoashi T, Kagisaki K, Ichikawa H, et al
    Staged repair of hemitruncus without prosthetic material.
    Asian Cardiovasc Thorac Ann. 2017;25:55-57.
    Abstract    

    Abstract available

  66. KAWABORI M, Kurata A
    Aortic penetration with sudden onset of dyspnea.
    Asian Cardiovasc Thorac Ann. 2017;25:78-79.
    Abstract    



  67. BHAT JI, Rather HA, Ahangar AA, Qureshi UA, et al
    Shoshin beriberi-thiamine responsive pulmonary hypertension in exclusively breastfed infants: A study from northern India.
    Indian Heart J. 2017;69:24-27.
    Abstract    

    Abstract available

  68. YANG F, Li D, Yang Z, Zhang Z, et al
    [Measurements of Pulmonary Artery Size for Assessment of Pulmonary Hypertension by Cardiovascular Magnetic Resonance and Clinical Application].
    Zhongguo Fei Ai Za Zhi. 2017;20:93-99.
    Abstract    

    Abstract available

  69. WU QY, Li DH, Li HY, Zhang MK, et al
    Surgical Treatment of Double Outlet Right Ventricle Complicated by Pulmonary Hypertension.
    Chin Med J (Engl). 2017;130:409-413.
    Abstract    

    Abstract available

  70. XU QX, Yang YH, Geng J, Zhai ZG, et al
    Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Chin Med J (Engl). 2017;130:382-391.
    Abstract    

    Abstract available

  71. VINCENT F, Lamblin N, Classe M, Schurtz G, et al
    Subacute right heart failure revealing three simultaneous causes of post-embolic pulmonary hypertension in metastatic dissemination of breast cancer.
    ESC Heart Fail. 2017;4:75-77.
    Abstract    

    Abstract available

  72. KOHNO T, Kataoka M, Kawakami T, Fukuoka R, et al
    Moderate-to-severe obstructive sleep apnea is associated with subclinical myocardial injury and impaired hemodynamics in pulmonary hypertension patients.
    Sleep Med. 2017;30:121-127.
    Abstract    

    Abstract available

  73. MIRDAMADI A, Gharavi H, Behjati M
    Role of Meticulous Observation: Successful Pregnancy in a 30-Year-Old Woman with Severe Pulmonary Hypertension.
    Tanaffos. 2016;15:187-190.
    Abstract    

    Abstract available

  74. MAZIMBA S, Holland E, Nagarajan V, Mihalek AD, et al
    Obesity paradox in group 1 pulmonary hypertension: Analysis of the NIH-pulmonary hypertension registry.
    Int J Obes (Lond). 2017 Feb 17. doi: 10.1038/ijo.2017.
    Abstract    

    Abstract available

  75. GAO H, Cheng Y, Zong L, Huang L, et al
    Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
    Clin Exp Hypertens. 2017 Jan 5:1-8. doi: 10.1080/10641963.2016.1210620.
    Abstract    

    Abstract available

  76. DRAGOMIR M, Petrescu DGE, Manga GE, Calin GA, et al
    Patients After Splenectomy: Old Risks and New Perspectives.
    Chirurgia (Bucur). 2016;111:393-399.
    Abstract    

    Abstract available

  77. NEVZOROVA VA, Kochetkova EA, Ugai LG, Maistrovskaya YV, et al
    [Role of vascular remodeling markers in the development of osteoporosis in idiopathic pulmonary arterial hypertension].
    Ter Arkh. 2016;88:65-70.
    Abstract    

    Abstract available

  78. CHEN YC, Yuan TY, Zhang HF, Wang DS, et al
    Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.
    Acta Pharmacol Sin. 2016;37:772-82.
    Abstract    

    Abstract available

  79. TAHARA N, Dobashi H, Fukuda K, Funauchi M, et al
    Efficacy and Safety of a Novel Endothelin Receptor Antagonist, Macitentan, in Japanese Patients With Pulmonary Arterial Hypertension.
    Circ J. 2016;80:1478-83.
    Abstract    

    Abstract available

  80. BRADY SM, Shapiro L, Mousa SA
    Current and future direction in the management of scleroderma.
    Arch Dermatol Res. 2016;308:461-71.
    Abstract    

    Abstract available

  81. MACRITCHIE N, Volpert G, Al Washih M, Watson DG, et al
    Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension.
    Cell Signal. 2016;28:946-55.
    Abstract    

    Abstract available

  82. KAWECKI D, Wojciechowska C, Jachec W, Krzemien-Wolska K, et al
    The influence of obstructive sleep breathing disturbances on echocardiographic and pulmonary haemodynamic parameters in patients with dilated cardiomyopathy.
    Kardiol Pol. 2016;74:135-41.
    Abstract    

    Abstract available

  83. ZUK M, Mazurkiewicz-Anton K, Migdal A, Jagiellowicz-Kowalska D, et al
    Prognosis in children with pulmonary arterial hypertension: 10-year single-centre experience.
    Kardiol Pol. 2016;74:159-67.
    Abstract    

    Abstract available

  84. ADESINA SE, Wade BE, Bijli KM, Kang BY, et al
    Hypoxia Inhibits Expression and Function of Mitochondrial Thioredoxin 2 to Promote Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2017 Jan 27:ajplung.00258.2016.
    Abstract    

    Abstract available

  85. MASTON LD, Jones DT, Giermakowska W, Howard TA, et al
    Central Role of T Helper 17 Cells in Chronic Hypoxia-Induced Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2017 Feb 17:ajplung.00531.2016.
    Abstract    

    Abstract available

  86. SCHERRER U, Verges S
    Sleep apnoea and pulmonary hypertension in high-altitude dwellers: more than an association?
    Eur Respir J. 2017;49.
    Abstract    



  87. OLIVEIRA RK, Agarwal M, Tracy JA, Karin AL, et al
    Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics.
    Eur Respir J. 2016;47:1179-88.
    Abstract    

    Abstract available

  88. CARAVITA S, Faini A, Deboeck G, Bondue A, et al
    Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component.
    J Heart Lung Transplant. 2016 Dec 23. pii: S1053-2498(16)30471.
    Abstract    

    Abstract available

  89. WEISMANN CG, Asnes JD, Bazzy-Asaad A, Tolomeo C, et al
    Pulmonary hypertension in preterm infants: results of a prospective screening program.
    J Perinatol. 2017 Feb 16. doi: 10.1038/jp.2016.
    Abstract    

    Abstract available

  90. HIMORI K, Abe M, Tatebayashi D, Lee J, et al
    Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension.
    PLoS One. 2017;12:e0169146.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;